journal article·2024-02-27Open access

Gold Nanoparticle-Based Colorimetric and Fluorescent Dual-Mode Lateral Flow Immunoassay for SARS-CoV-2 Detection

Ying Gan, Hefan Zhang, Jing Liu, Fuqin He, Fengheng Li, Ao Li, Man Xing, Dongming Zhou, Shan-Yu Fung, Hong Yang

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection caused the COVID-19 pandemic, impacting the global economy and medical system due to its fast spread and extremely high infectivity. Efficient control of the spread of the disease relies on a fast, accurate, and convenient detection system for the early screening of the infected population. Although reverse transcription–quantitative polymerase chain reaction (RT-qPCR) is the gold-standard method for SARS-CoV-2 RNA analysis, it has complex experimental procedures and relies on expensive instruments and professional operators. In this work, we proposed a simple, direct, amplification-free lateral flow immunoassay (LFIA) with dual-mode detection of SARS-CoV-2 RNA via direct visualization as well as fluorescence detection. The viral RNA was detected by the designed DNA probes to specifically hybridize with the conserved open reading frame 1ab (ORF1ab), envelope protein (E), and nucleocapsid (N) regions of the SARS-CoV-2 genome to form DNA–RNA hybrids. These hybrids were then recognized by the dual-mode gold nanoparticles (DMNPs) to produce two different readout signals. The fluorescence characteristics of different sizes of GNPs were explored. Under the optimized conditions, the LFIA presented a linear detection range of 104–106 TU/mL with a limit of detection (LOD) of 0.76, 1.83, and 2.58 × 104 TU/mL for lentiviral particles carrying SARS-CoV-2 ORF1ab, E, and N motifs, respectively, in the fluorescent mode, which was up to 10 times more sensitive than the colorimetric mode. Furthermore, the LFIA exhibited excellent specificity to SARS-CoV-2 in comparison with other respiratory viruses. It could be used to detect SARS-CoV-2 in saliva samples. The developed LFIA represents a promising and convenient point-of-care method for dual-mode, rapid detection of SARS-CoV-2, especially in the periods with high infectivity.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: SARS-CoV-2 detection and testing · Biosensors and Analytical Detection · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Inflammatory Biology, Department of Pharmacology, School of Basic Medical Sciences, Tianjin Medical University, No. 22 Qixiangtai Road, Heping District, Tianjin 300070, China

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, No. 22 Qixiangtai Road, Heping District, Tianjin 300070, China

Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, Zhejiang University, Hangzhou 310027, China

Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China

Funding

Natural Science Foundation of the Tianjin Municipal Science and Technology Commission · National Natural Science Foundation of China

References (42)

Show source-provided references
1. A new coronavirus associated with human respiratory disease in China10.1038/s41586-020-2008-3 ↗
2. The immunology of COVID-19: Is immune modulation an option for treatment?10.1016/S2665-9913(20)30120-X ↗
3. World health organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)10.1016/j.ijsu.2020.02.034 ↗
4. Molecular architecture of the SARS-CoV-2 virus10.1016/j.cell.2020.09.018 ↗
5. Coronavirus disease 2019 (COVID-19): A literature review10.1016/j.jiph.2020.03.019 ↗
6. Ye, Z.W., Yuan, S.F., Yuen, K.S., Fung, S.Y., Chan, C.P., and Jin, D.Y. (2020). Zoonotic origins of human coronaviruses. Int. J. Biol. Sci., 16.10.7150/ijbs.45472 ↗
7. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?10.1016/j.ejrad.2020.108961 ↗
8. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR10.2807/1560-7917.ES.2020.25.3.2000045 ↗
9. Electrochemical sensors for the detection of SARS-CoV-2 virus10.1016/j.cej.2021.132966 ↗
10. Gan, Y., Zhou, M.X., Ma, H.Q., Gong, J.M., Fung, S.Y., Huang, X., and Yang, H. (2022). Silver nano-reporter enables simple and ultrasensitive profiling of microRNAs on a nanoflower-like microelectrode array on glass. J. Nanobiotechnol., 20.10.1186/s12951-022-01664-7 ↗
11. Quesada-González, D., and Merkoçi, A. (2015). Nanoparticle-based lateral flow biosensors. Biosens. Bioelectron., 73.10.1016/j.bios.2015.05.050 ↗
12. Sensitive and simultaneous detection of multi-index lung cancer biomarkers by an NIR-Ⅱ fluorescence lateral-flow immunoassay platform10.1016/j.cej.2022.135204 ↗
13. SARS-CoV-2 point-of-care (POC) diagnosis based on commercial pregnancy test strips and a palm-size microfluidic device10.1021/acs.analchem.1c01829 ↗
14. Rapid point-of-care testing for SARS-CoV-2 virus nucleic acid detection by an isothermal and nonenzymatic Signal amplification system coupled with a lateral flow immunoassay strip10.1016/j.snb.2021.129899 ↗
15. Tri-primer-enhanced strand exchange amplification combined with rapid lateral flow fluorescence immunoassay to detect SARS-CoV-210.1039/D1AN00858G ↗
16. Wang, D.M., He, S.G., Wang, X.H., Yan, Y.Q., Liu, J.Z., Wu, S.M., Liu, S.G., Lei, Y., Chen, M., and Li, L. (2020). Rapid lateral flow immunoassay for the fluorescence detection of SARS-CoV-2 RNA. Nat. Biomed. Eng., 4.10.1038/s41551-020-00655-z ↗
17. Yadav, S., Sadique, M.A., Ranjan, P., Kumar, N., Singhal, A., Srivastava, A.K., and Khan, R. (2021). SERS based lateral flow immunoassay for point-of-care detection of SARS-CoV-2 in clinical samples. ACS Appl. Bio Mater., 4.10.1021/acsabm.1c00102 ↗
18. SERS-based lateral flow immunoassay for sensitive and simultaneous detection of anti-SARS-CoV-2 IgM and IgG antibodies by using gap-enhanced Raman nanotags10.1016/j.snb.2021.130706 ↗
19. Rapid field determination of SARS-CoV-2 by a colorimetric and fluorescent dual-functional lateral flow immunoassay biosensor10.1016/j.snb.2021.130897 ↗
20. Dual-mode SERS-based lateral flow assay strips for simultaneous diagnosis of SARS-CoV-2 and influenza a virus10.1186/s40580-022-00330-w ↗
21. Sensitive and simultaneous detection of SARS-CoV-2-specific IgM/IgG using lateral flow immunoassay based on dual-mode quantum dot nanobeads10.1021/acs.analchem.0c03484 ↗
22. Ultrasensitive and simultaneous detection of two specific SARS-CoV-2 antigens in human specimens using direct/enrichment dual-mode fluorescence lateral flow immunoassay10.1021/acsami.1c11461 ↗
23. Diagnostics for SARS-CoV-2 infections10.1038/s41563-020-00906-z ↗
24. Rapid isothermal amplification and portable detection system for SARS-CoV-210.1073/pnas.2014739117 ↗
25. A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-210.1016/j.chom.2020.03.002 ↗
26. Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes10.1080/22221751.2020.1729071 ↗
27. Jiao, J., Duan, C., Xue, L., Liu, Y., Sun, W., and Xiang, Y. (2020). DNA nanoscaffold-based SARS-CoV-2 detection for COVID-19 diagnosis. Biosens. Bioelectron., 167.10.1016/j.bios.2020.112479 ↗
28. Presumed asymptomatic carrier transmission of COVID-1910.1001/jama.2020.2565 ↗
29. Molès, J.-P., Griez, A., Guilhou, J.-J., Girard, C., Nagot, N., Van de Perre, P., and Dujols, P. (2017). Cytosolic RNA:DNA duplexes generated by endogenous reverse transcriptase activity as autonomous inducers of skin inflammation in psoriasis. PLoS ONE, 12.10.1371/journal.pone.0169879 ↗
30. Nava, G.M., Grasso, L., Sertic, S., Pellicioli, A., Muzi Falconi, M., and Lazzaro, F. (2020). One, no one, and one hundred thousand: The many forms of ribonucleotides in DNA. Int. J. Mol. Sci., 21.10.3390/ijms21051706 ↗
31. Nano-enabled reposition of proton pump inhibitors for TLR inhibition: Toward a new targeted nanotherapy for acute lung injury10.1002/advs.202104051 ↗
32. Enhanced anti-inflammatory activity of peptide-gold nanoparticle hybrids upon cigarette smoke extract modification through TLR inhibition and autophagy induction10.1021/acsami.9b10536 ↗
33. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing10.1038/s41586-020-2286-9 ↗
34. A versatile strategy of designing gold nanoparticle–cDNA nanoprobes in developing aptamer-based lateral flow assay for small-molecule detection10.1021/acs.langmuir.3c00645 ↗
35. Rapid detection of IgM antibodies against the SARS-CoV-2 virus via colloidal gold nanoparticle-based lateral-flow assay10.1021/acsomega.0c01554 ↗
36. Fluorescence quenching of dye molecules near gold nanoparticles: Radiative and nonradiative effects10.1103/PhysRevLett.89.203002 ↗
37. Reverse fluorescence enhancement and colorimetric bimodal signal readout immunochromatography test strip for ultrasensitive large-scale screening and postoperative monitoring10.1021/acsami.6b08445 ↗
38. Distance-dependent interactions between gold nanoparticles and fluorescent molecules with DNA as tunable spacers10.1088/0957-4484/20/48/485201 ↗
39. Tsuruoka, M., Yano, K., Ikebukuro, K., Nakayama, H., Masuda, Y., and Karube, I. (1996). Optimization of the rate of DNA hybridization and rapid detection of methicillin resistant Staphylococcus aureus DNA using fluorescence polarization. J. Biotechnol., 48.10.1016/0168-1656(96)01510-6 ↗
40. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: A cohort study10.1016/S1473-3099(20)30985-3 ↗
41. Ultrasensitive lateral-flow assays via plasmonically active antibody-conjugated fluorescent nanoparticles10.1038/s41551-022-01001-1 ↗
42. RNase in the saliva can affect the detection of severe acute respiratory syndrome coronavirus 2 by real-time one-step polymerase chain reaction using saliva samples10.1016/j.prp.2021.153381 ↗